| Literature DB >> 33096040 |
Jenna J Guthmiller1, Linda Yu-Ling Lan2, Monica L Fernández-Quintero3, Julianna Han4, Henry A Utset1, Dalia J Bitar1, Natalie J Hamel1, Olivia Stovicek1, Lei Li1, Micah Tepora1, Carole Henry1, Karlynn E Neu5, Haley L Dugan2, Marta T Borowska6, Yao-Qing Chen1, Sean T H Liu7, Christopher T Stamper2, Nai-Ying Zheng1, Min Huang1, Anna-Karin E Palm1, Adolfo García-Sastre8, Raffael Nachbagauer7, Peter Palese7, Lynda Coughlan9, Florian Krammer7, Andrew B Ward4, Klaus R Liedl3, Patrick C Wilson10.
Abstract
Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.Entities:
Keywords: antibody flexibility; broadly neutralizing antibodies; influenza viruses; monoclonal antibodies; polyreactivity
Mesh:
Substances:
Year: 2020 PMID: 33096040 PMCID: PMC7772752 DOI: 10.1016/j.immuni.2020.10.005
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745